First Generic Moxidectin Injectable Solution Now Available

Cattle on pasture.
Cattle on pasture.
(Troy Walz)

Norbrook announces the introduction of Tauramox (moxidectin) Injectable Solution to control key internal and external parasites in beef and dairy cattle.

According to Dr. Eric Moore, DVM and director of technical services for Norbrook, internal and external parasites routinely cause a range of problems for both beef and dairy cattle, potentially limiting their opportunities for weight gain and reducing their milk production.

Tauromox“At some point in their lifetime, all cattle are exposed to parasites,” says Moore. “To maximize the efficacy of a deworming program, it’s crucial to understand which parasite lifecycle you are combatting. Your program should include targeting a broad range of parasites. The active ingredient in Tauramox (moxidectin) is an effective dewormer that targets both internal parasites such as gastrointestinal roundworms (including Ostertagia), lungworms and external parasites such as grubs, mites and lice.

“One unique benefit of the moxidectin molecule is that it doesn’t decimate dung beetle populations, which are a key factor in maintaining soil health in pastures,” adds Moore. “Moxidectin, the active ingredient in Tauramox, is dung beetle friendly.”1  

Recommendations For Use

Tauramox has a short, 21-day pre-slaughter withdrawal time, and producers can expect the same weight gain advantage as with Cydectin Injectable and at a lower price, according to Moore. Tauramox  is approved for use in beef cattle 8 weeks of age and older, and in nonlactating dairy cows 8 weeks to 20 months of age. It is not approved for use in veal calves. It is available in 500 mL bottles.

Noromycin 300 LA (oxytetracycline injection) No Longer Available Over the Counter 
As stipulated by the new FDA guidelines regarding antibiotic distribution and availability, which went into effect in June of this year, many key antibiotics that were once available over the counter are now available through prescription only.  In particular, Noromycin 300 LA is ideal for multiple treatment protocols and is newly labeled for flexible dosing at higher ranges (9 mg/lb-13.6 mg/lb), under the direction of a veterinarian. Noromycin 300 LA takes the place of a product once only available through a prescription, 300 PRO LA (oxytetracycline injection).

It’s critical that veterinarians have Noromycin on shelves before the fluctuating temperatures and weather conditions of fall and winter, weaning stress and comingling cause BRD outbreaks in the coming months.

For more information about Norbrook and its portfolio of cattle products, visit Norbrook.com. 

1Jacobs, C.T. & Scholtz, C.H., 2015, ‘A review on the effect of macrocyclic lactones on dung-dwelling insects: Toxicity of macrocyclic lactones to dung beetles’, Onderstepoort Journal of Veterinary Research 82(1), Art. #858, 8 pages. http://dx.doi.org/10.4102/ojvr.v82i1.858

Effective Strategies to Control Internal Parasites

Winter Tick: What You Need to Know

Veterinary Viewpoints: Controlling Internal Parasites In Sheep And Goats

Tauramox IMPORTANT SAFETY INFORMATION:  Cattle must not be slaughtered for human consumption within 21 days of treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for preruminating calves. Do not use in calves to be processed for veal.

Noromycin 300 LA CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Observe label directions and withdrawal times. Not for use in lactating dairy animals. Adverse reactions, including injection site welling, restlessness, ataxia, trembling, respiratory abnormalities (labored breathing), collapse and possibly death have been reported. See product labeling for full product information.

300 PRO LA CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Observe label directions and withdrawal times. Not for use in lactating dairy animals. Adverse reactions, including injection site swelling, restlessness, ataxia, trembling, respiratory abnormalities (labored breathing), collapse and possibly death have been reported. See product labeling for full product information.

 

Latest News

Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities
Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities

The Meat Institute said properly prepared beef remains safe to eat and called for USDA and the CDC to provide worker safety guidance specific to beef processors to ensure workers are protected from infection.

 A Message to the Ag Industry about H5N1
A Message to the Ag Industry about H5N1

The livestock industry needs a comprehensive, cohesive plan to address the virus. Producers, their employees and veterinarians need clear answers and support from U.S. agricultural leadership, moving forward.

USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread
USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread

USDA is now ordering all dairy cattle must be tested prior to interstate travel as a way to help stop the spread of HPAI H5N1. This comes a day after FDA confirmed virus genetic material was found in retail milk samples.

Mistrial Declared in Arizona Rancher’s Murder Trial
Mistrial Declared in Arizona Rancher’s Murder Trial

A lone juror stood between rancher George Kelly and innocent. “It is what it is, and it will be what it will be. Let me go home, okay?”

USDA Shares Recent H5N1 Avian Flu Sequences
USDA Shares Recent H5N1 Avian Flu Sequences

APHIS announced it has shared 239 genetic sequences of the H5N1 avian flu virus which will help scientists look for new clues about the spread of the virus.

Fairlife Breaks Ground on $650 Million Facility in New York
Fairlife Breaks Ground on $650 Million Facility in New York

Fairlife is known for its value-added dairy products, such as ultra-filtered milk, protein shakes and lactose-free milk. Soon, the company will be producing these popular products at its upcoming facility in N.Y.